Jim Cramer recently discussed Pfizer Inc. (NYSE:PFE) and its unique trading behavior, comparing it to a bond due to its 7% dividend yield. CEO Albert Bourla addressed concerns about stock valuation, tariffs, COVID revenue, and drug exclusivity loss. Despite PFE’s potential, AI stocks may offer higher returns.

In his discussion with Bourla, Cramer expressed disbelief at Pfizer’s stock level given its strong fundamentals. While PFE may be a solid investment, some AI stocks are seen as having greater potential for returns and minimal downside risk. Investors interested in AI stocks should explore opportunities beyond Pfizer.

For more insights on potential stocks that could double in three years or hidden AI stocks to buy now, check out the related articles. This information is provided by Insider Monkey.

Read more at Yahoo Finance: Jim Cramer Finds Pfizer (PFE)’s Stock Level “Unfathomable”